Skip to content
WeighLab
Menu
Ranked #16 · Grade B

PepHaūs review

Mid-market $152/$246 pricing on both molecules, all-50 and LegitScript-verified — a clean, verified nationwide option that trades rock-bottom cost for a dependable pharmacy.

Visit PepHaūs Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. See our disclosure.
Semaglutide
$152/mo
Tirzepatide
$246/mo
Coverage
All 50 states
Brand-name
Compounded only

Semaglutide · modeled / year

$1,824

Tirzepatide · modeled / year

$2,952

The Index scorecard

PepHaūs scored on our six Cost-Efficiency Index factors. See the methodology.

Normalized Cost/Month80/100
Price Transparency86/100
Nationwide Access96/100
Formulation Options78/100
Clinical Oversight86/100
Contract Flexibility82/100

Where the value is

  • Both molecules disclosed at flat prices with nationwide all-50 access
  • LegitScript-certified pharmacy behind the program
  • Predictable pricing that's straightforward to model for a year

The tradeoffs

  • $152/$246 is mid-market — undercut on raw cost by several verified all-50 rivals
  • Compounded only — no brand-name or oral option

The bottom line

Best for: People who want a verified all-50 program with both molecules disclosed and will pay mid-market for the peace of mind. Mid-market $152/$246 pricing on both molecules, all-50 and LegitScript-verified — a clean, verified nationwide option that trades rock-bottom cost for a dependable pharmacy.

Ranked #16 of 25 providers on the Cost-Efficiency Index — see our #1 pick, CoreAge Rx, for comparison.

Compare with other providers

All 24 other providers we've modeled, in Cost-Efficiency Index order.

Pricing, states and verification reflect PepHaūs's public disclosures at last review; the Cost-Efficiency Index is our editorial judgment per the methodology. Prices change — confirm on PepHaūs's site. Not medical advice; see our disclosure.

← Back to the value leaderboard